Affiliation: University of Arkansas for Medical Sciences, Department of Biochemistry and Molecular Biology

Dr. Nathan Avaritt is an Instructor in the Department of Biochemistry and Molecular Biology at the University of Arkansas for Medical Sciences, where he also completed his Ph.D. in 2014 with a focus on the epigenetic regulation of melanoma progression and on developing methods to effectively utilize fixed tissue samples for proteomics analysis. From 2014 to 2016, Dr. Avaritt worked in the environmental compliance field but was recruited back to UAMS in early 2016 to establish the Developmental Proteomics Laboratory in partnership with Dr. Alan Tackett at the Arkansas Children’s Research Institute (ACRI). In this capacity, Dr. Avaritt facilitated collaborative and translational research projects for dozens of clinicians and scientists, developed the first-in-the-state single cell sequencing pipeline, and also maintained his own research efforts in the field of melanoma epigenetics. In 2020, Dr. Avaritt transitioned from ACRI to the Winthrop P. Rockefeller Cancer Institute to guide and manage a National Cancer Institute research program investigating novel melanoma therapeutics.​​